Published on 26 Feb 2024 on Zacks via Yahoo Finance
Why Vaxcyte (PCVX) Might Surprise This Earnings Season
Investors are always looking for stocks that are poised to beat at earnings season and Vaxcyte, Inc. PCVX may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Vaxcyte is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for PCVX in this report.In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 79 cents per share for PCVX, compared to a broader Zacks Consensus Estimate of a loss of 90 cents per share. This suggests that analysts have very recently bumped up their estimates for PCVX, giving the stock a Zacks Earnings ESP of +12.29% heading into earnings season.
Vaxcyte, Inc. Price and EPS Surprise
